Higher T-SPOT.TB threshold may aid in diagnosing active tuberculosis?: A real-world clinical practice in a general hospital

Organization, 2019 Wallis, 2013, Tuberculosis biomarkers discovery: developments, needs, and challenges, Lancet. Infect. Dis, 13, 362, 10.1016/S1473-3099(13)70034-3 Dorman, 2018, Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study, Lancet. Infect. Dis, 18, 76, 10.1016/S1473-3099(17)30691-6 Andersen, 2000, Specific immune-based diagnosis of tuberculosis, Lancet, 356, 1099, 10.1016/S0140-6736(00)02742-2 Pai, 2008, Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update, Ann. Intern. Med., 149, 177, 10.7326/0003-4819-149-3-200808050-00241 Yang, 2020, Preventive tuberculosis treatment effect on QuantiFERON TB-Gold in-tube testing in a high tuberculosis-endemic country: A clinical trial, Int. J. Infect. Dis., 91, 182, 10.1016/j.ijid.2019.11.023 Zhang, 2019, Serial T-SPOT.TB in household contacts of tuberculosis patients: a 6-year observational study in China, Int. J. Tuberc. Lung Dis., 23, 989, 10.5588/ijtld.18.0252 Ma, 2019, Clinical effect of T-SPOT.TB test for the diagnosis of tuberculosis, BMC Infect. Dis., 19, 993, 10.1186/s12879-019-4597-8 Sester, 2011, Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis, Eur. Respir. J., 37, 100, 10.1183/09031936.00114810 Zhou, 2017, Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy, Front. Cell Infect. Microbiol., 7, 457, 10.3389/fcimb.2017.00457 Wang, 2016, Using the TBAg/PHA ratio in the T-SPOT((R)).TB assay to distinguish TB disease from LTBI in an endemic area, Int. J. Tuberc. Lung. Dis., 20, 487, 10.5588/ijtld.15.0756 Janssens, 2007, Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis, Eur. Respir. J., 30, 722, 10.1183/09031936.00028507 Wang, 2018, Evaluation of the performance of two tuberculosis interferon gamma release assays (IGRA-ELISA and T-SPOT. TB) for diagnosing Mycobacterium tuberculosis infection, Clin. Chim. Acta, 479, 74, 10.1016/j.cca.2018.01.014 Pai, 2014, Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection, Clin. Microbiol. Rev., 27, 3, 10.1128/CMR.00034-13 Ling, 2013, Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis, Thorax, 68, 860, 10.1136/thoraxjnl-2012-203086 Adetifa, 2013, Interferon-gamma ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial, Am. J. Respir. Crit. Care Med., 187, 439, 10.1164/rccm.201208-1352OC Pathan, 2001, Direct Ex Vivo Analysis of Antigen-Specific IFN- -Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment, J. Immunol., 167, 5217, 10.4049/jimmunol.167.9.5217 Chee, 2007, Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens, Am. J. Respir. Crit. Care Med., 175, 282, 10.1164/rccm.200608-1109OC Zhu, 2014, The performance and limitation of T-SPOT.TB for the diagnosis of TB in a high prevalence setting, J. Thorac. Dis., 6, 713 Yang, 2018, Evaluation of risk factors for false-negative results with an antigen-specific peripheral blood-based quantitative T cell assay (T-SPOT((R)). TB) in the diagnosis of active tuberculosis: A large-scale retrospective study in China, J. Int. Med. Res., 46, 1815, 10.1177/0300060518757381 Kuo, 2013, Type 2 diabetes: an independent risk factor for tuberculosis: a nationwide population-based study, PLoS ONE, 8, 10.1371/journal.pone.0078924 Faurholt-Jepsen, 2014, Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls, Scand J. Infect. Dis., 46, 384, 10.3109/00365548.2014.885657 Organization, 2018 Siegel, 2018, Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay, J. Clin. Microbiol., 56, e00629, 10.1128/JCM.00629-18 Pourakbari, 2019, Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-γ release assays: A systematic review and meta-analysis, Adv. Med. Sci., 64, 437, 10.1016/j.advms.2019.09.001 Sotgiu, 2019, QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis, J. Infect., 79, 444, 10.1016/j.jinf.2019.08.018 Whitworth, 2019, Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study, Lancet. Infect. Dis., 19, 193, 10.1016/S1473-3099(18)30613-3 Sohn, 2014, Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact, Clin. Infect. Dis., 58, 970, 10.1093/cid/ciu022 Papay, 2011, Factors impacting the results of interferon-gamma release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases, Inflamm. Bowel. Dis., 17, 84, 10.1002/ibd.21427 Arias-Guillén, 2014, T-Cell Profiling and the Immunodiagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease, Inflamm. Bowel Dis., 20, 329, 10.1097/01.MIB.0000438429.38423.62 Kleinert, 2012, Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions, Ann. Rheum. Dis., 71, 1791, 10.1136/annrheumdis-2011-200941 Shaikh, 2017, Novel interferon-gamma assays for diagnosing tuberculosis in young children in India, Int. J. Tuberc. Lung Dis., 21, 412, 10.5588/ijtld.16.0428 Meier, 2019, Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis, Front. Pediatr., 7, 208, 10.3389/fped.2019.00208 Nguyen, 2018, Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015, Emerg. Infect. Dis., 24, 534, 10.3201/eid2403.171633 Lian, 2017, Factors contributing to false-negative enzyme-linked immunospot assay for interferon-gamma results in active tuberculosis, Clin. Lab., 63, 773, 10.7754/Clin.Lab.2016.161007